T1	Pharmacological_substance 21 28	rhIL-11
N1000 	Reference T1 MeSH:C105308	rhIL-11
T6	Pharmacological_substance 102 109	rhIL-11
N1001 	Reference T6 MeSH:C105308	rhIL-11
T7	Pharmacological_substance 125 135	oprelvekin
N1002 	Reference T7 MeSH:C105308	oprelvekin
T9	Pharmacological_substance 137 144	Neumega
N1003 	Reference T9 MeSH:C105308	Neumega
T10	Disorder 164 187	nonmyeloid malignancies
T13	Pharmacological_substance 584 591	rhIL-11
N1004 	Reference T13 MeSH:C105308	rhIL-11
T15	Pharmacological_substance 741 748	rhIL-11
N1005 	Reference T15 MeSH:C105308	rhIL-11
T16	Pharmacological_substance 838 845	rhIL-11
N1006 	Reference T16 MeSH:C105308	rhIL-11
T17	Disorder 982 994	solid tumors
N1 	Reference T17 UMLS:C0027651	solid tumors
T18	Pharmacological_substance 1007 1014	rhIL-11
N1007 	Reference T18 MeSH:C105308	rhIL-11
T20	Pharmacological_substance 1035 1072	granulocyte colony-stimulating factor
N1008 	Reference T20 MeSH:D016179	granulocyte colony-stimulating factor
T21	Pharmacological_substance 1074 1079	G-CSF
N1009 	Reference T21 MeSH:D016179	G-CSF
N1010 	Reference T21 MeSH:D016179	G-CSF
T22	Pharmacological_substance 1081 1091	filgrastim
N1011 	Reference T22 MeSH:D000069585	filgrastim
T23	Pharmacological_substance 1238 1245	rhIL-11
N1012 	Reference T23 MeSH:C105308	rhIL-11
T27	Pharmacological_substance 1473 1480	rhIL-11
N1013 	Reference T27 MeSH:C105308	rhIL-11
T31	Pharmacological_substance 1684 1691	rhIL-11
N1014 	Reference T31 MeSH:C105308	rhIL-11
T2	Subject 150 158	patients
T4	Pharmacological_substance 30 37	Placebo
N1015 	Reference T4 MeSH:D010919	Placebo
T32	Manner_cue 206 217	significant
T33	Disorder 241 297	postchemotherapy platelet nadirs of < or = 20,000/microL
T37	Pharmacological_substance 456 463	rhIL-11
N1016 	Reference T37 MeSH:C105308	rhIL-11
T38	Subject 549 567	untreated patients
T19	Pharmacological_substance 1093 1101	Neupogen
N1017 	Reference T19 MeSH:D000069585	Neupogen
T40	Combination 1018 1029	combination
T12	Subject 958 976	pediatric patients
T3	Pharmacological_substance 68 100	recombinant human interleukin-11
N1018 	Reference T3 MeSH:C105308	recombinant human interleukin-11
T8	Pharmacological_substance 491 503	chemotherapy
N1019 	Reference T8 MeSH:C403362	chemotherapy
N1020 	Reference T8 MeSH:D004113	chemotherapy
N1021 	Reference T8 MeSH:C057647	chemotherapy
T14	Pharmacological_substance 905 917	chemotherapy
N1022 	Reference T14 MeSH:C403362	chemotherapy
N1023 	Reference T14 MeSH:D004113	chemotherapy
N1024 	Reference T14 MeSH:C057647	chemotherapy
